万孚生物：累计回购约143万股

Group 1 - The company Wanfu Biology (SZ 300482) announced a share buyback plan, with the actual buyback period from September 26, 2025, to November 21, 2025 [1] - As of November 21, 2025, the company repurchased approximately 1.43 million shares, accounting for 0.3059% of the total share capital, with a total transaction amount of about 30.09 million yuan [1] - The buyback exceeded the lower limit of the planned repurchase quantity and did not exceed the upper limit, indicating the completion of the buyback plan [1] Group 2 - For the year 2024, the revenue composition of Wanfu Biology is as follows: diagnostic products account for 97.59%, while other products account for 2.41% [1] - The current market capitalization of Wanfu Biology is 9.7 billion yuan [1]